In silico investigation of the effects of Gentamicin on lysosomal lipid degradation and the transport system between lysosomes and smooth endoplasmic reticulum
Medicinska istrazivanja · 2026 · (00) · 13-13
DOI: 10.5937/medi0-66721 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medicinska istrazivanja, 2026. Verfasst von Nikola Mitović und 9 weiteren Autor:innen. Die Arbeit nennt 20 Literaturangaben. Gefördert von: Ministry of Education, Science and Technological Development of the Republic of Serbia.
Abstract (Originalsprache)
Introduction
Gentamicin, an aminoglycoside antibiotic, has limited clinical use due to accompanying side effects: nephrotoxicity and ototoxicity. The damage caused by Gentamicin accumulates over time, leading to cell death. Cells of renal proximal tubules are most affected, as are hair cells of the inner ear. One of the presumed mechanisms of toxicity is phospholipidosis, a disorder characterized by the accumulation of phospholipids within cells.
Aim
This study aims to investigate, in silico, the mechanism of Gentamicin action in the development of phospholipidosis through interactions with key proteins responsible for lipid transport between the smooth endoplasmic reticulum and late endosomes, as well as enzymes involved in lipid degradation. Material and Methods: We defined target proteins in the KEGG database, and their expression profiles and tissue-specificities were examined using the Human Atlas database. Nine proteins met the final criteria and were further examined by molecular docking using AutoDock Vina.
Results
Most of the examined proteins showed high expression in the kidney and corresponding structures of the central nervous system. Docking analysis indicated that the interaction between Gentamicin and ORP1L protein exhibited the lowest Gibbs free energy value of - 8.1 kcal/mol. In comparison, the STARD3 protein had the highest Gibbs free energy value of -5.2 kcal/mol. Amino acid sequences to which Gentamicin binds on the selected proteins were similar within the same protein families.
Conclusion
Observed under in silico conditions, Gentamicin interacts with proteins that participate in lysosomal lipid degradation and transport between lysosomes and smooth endoplasmic reticulum.
Förderung
- Ministry of Education, Science and Technological Development of the Republic of Serbia
Zitieren
APA
Mitović, N., Spasić, S., Jovanović, N., Stanojević, M., Paunović-Pantić, J., Kovačević, S., Gostiljac, D., Jovičić, V., Jevtović, J., & Nešović-Ostojić, J. (2026). In silico investigation of the effects of Gentamicin on lysosomal lipid degradation and the transport system between lysosomes and smooth endoplasmic reticulum. Medicinska istrazivanja, 13-13. https://doi.org/10.5937/medi0-66721
Vancouver
Mitović N, Spasić S, Jovanović N, Stanojević M, Paunović-Pantić J, Kovačević S, et al. In silico investigation of the effects of Gentamicin on lysosomal lipid degradation and the transport system between lysosomes and smooth endoplasmic reticulum. Medicinska istrazivanja. 2026:13-13. doi:10.5937/medi0-66721
BibTeX
@article{Mitovi2026,
author = {Mitović, Nikola and Spasić, Svetolik and Jovanović, Nikola and Stanojević, Marija and Paunović-Pantić, Jovana and Kovačević, Sanjin and Gostiljac, Draško and Jovičić, Vladimir and Jevtović, Jelena and Nešović-Ostojić, Jelena},
title = {In silico investigation of the effects of Gentamicin on lysosomal lipid degradation and the transport system between lysosomes and smooth endoplasmic reticulum},
journal = {Medicinska istrazivanja},
year = {2026},
number = {00},
pages = {13--13},
doi = {10.5937/medi0-66721}
}
EUVIMED